Skipping radiation for younger women with low-risk DCIS
Treatments studied
Part of Cancer clinical trials.
This study is looking at whether it is safe for younger women who have had surgery for a very early-stage, low-risk breast condition called DCIS to skip radiation therapy. The goal is to see if they can avoid the side effects of radiation without the cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman under 40 years old.
- You have been diagnosed with low- or intermediate-grade DCIS and had surgery to remove it.
- The area of DCIS was small (1 cm or smaller), and the margins (tissue around the removed area) were clear of cancer cells.
- The DCIS was found on a routine screening, and you did not have symptoms like a lump or nipple discharge.
- You do not have a history of breast cancer in the other breast or a known BRCA gene mutation.
- You are willing to have your tissue samples reviewed and follow up as scheduled.
- fitModel-info-ignored
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares skipping radiation therapy after breast-conserving surgery for low- or intermediate-risk ductal carcinoma in situ (DCIS) – a very early, non-invasive breast cancer. It aims to see if omitting radiation is as effective as standard treatment while reducing side effects.
This trial tests whether some women with low-risk breast cancer that has spread to a few lymph nodes can safely skip radiation therapy after surgery. It aims to reduce side effects while keeping the cancer from coming back.
This trial studies whether removing the abnormal breast cells with breast-conserving surgery only (without additional treatment) is enough for people with low-risk ductal carcinoma in situ (DCIS). It may help some patients avoid extra treatments if their risk is very low.
This trial tests whether older women with very low-risk, hormone-positive breast cancer can safely skip endocrine therapy (hormone-blocking pills) and radiation after lumpectomy. It aims to maintain quality of life while keeping cancer from coming back.
This trial tests whether women with very low-risk, early-stage breast cancer can safely skip hormone therapy after surgery. It is designed for women who are 60 or older and whose cancer shows no spread to lymph nodes and has favorable biology.
This trial studies giving radiation during surgery for women with a certain early breast condition called ductal carcinoma in situ (DCIS). It may help lower the chance that the DCIS comes back, especially when combined with breast-conserving surgery.
Hear when a new Ductal Carcinoma In Situ, DCIS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.